PIM1 and squamous cell carcinoma: PIM1 expression was examined in 134 NSCLC patients (56 adenocarcinomas, 65 squamous cell carcinomas and 13 of other histology) of various stages (I–IV) by immunohistochemical analysis (Table S1).